Structure

Physi-Chem Properties

Molecular Weight:  540.18
Volume:  499.264
LogP:  0.488
LogD:  0.486
LogS:  -3.003
# Rotatable Bonds:  9
TPSA:  197.13
# H-Bond Aceptor:  13
# H-Bond Donor:  6
# Rings:  5
# Heavy Atoms:  13

MedChem Properties

QED Drug-Likeness Score:  0.124
Synthetic Accessibility Score:  5.005
Fsp3:  0.64
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.465
MDCK Permeability:  6.698349170619622e-05
Pgp-inhibitor:  0.008
Pgp-substrate:  0.97
Human Intestinal Absorption (HIA):  0.959
20% Bioavailability (F20%):  0.275
30% Bioavailability (F30%):  0.998

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.209
Plasma Protein Binding (PPB):  54.313697814941406%
Volume Distribution (VD):  0.407
Pgp-substrate:  26.9220027923584%

ADMET: Metabolism

CYP1A2-inhibitor:  0.009
CYP1A2-substrate:  0.096
CYP2C19-inhibitor:  0.011
CYP2C19-substrate:  0.343
CYP2C9-inhibitor:  0.002
CYP2C9-substrate:  0.085
CYP2D6-inhibitor:  0.003
CYP2D6-substrate:  0.167
CYP3A4-inhibitor:  0.02
CYP3A4-substrate:  0.058

ADMET: Excretion

Clearance (CL):  1.794
Half-life (T1/2):  0.785

ADMET: Toxicity

hERG Blockers:  0.085
Human Hepatotoxicity (H-HT):  0.249
Drug-inuced Liver Injury (DILI):  0.084
AMES Toxicity:  0.337
Rat Oral Acute Toxicity:  0.168
Maximum Recommended Daily Dose:  0.005
Skin Sensitization:  0.684
Carcinogencity:  0.079
Eye Corrosion:  0.003
Eye Irritation:  0.011
Respiratory Toxicity:  0.924

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC478248

Natural Product ID:  NPC478248
Common Name*:   3,4-dihydro-6-O-di-trans-feruloyl catalpol
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  UNLUMIAUTMNYAF-WDXKYWDXSA-N
Standard InCHI:  InChI=1S/C25H32O13/c1-33-14-8-11(2-4-13(14)28)3-5-16(29)36-21-12-6-7-34-23(17(12)25(10-27)22(21)38-25)37-24-20(32)19(31)18(30)15(9-26)35-24/h2-5,8,12,15,17-24,26-28,30-32H,6-7,9-10H2,1H3/b5-3+/t12-,15?,17-,18+,19?,20+,21+,22+,23+,24+,25-/m1/s1
SMILES:  [H][C@]12[C@H](O[C@@H]3OC(CO)[C@H](O)C(O)[C@@H]3O)OCC[C@@]1([H])[C@H](OC(=O)/C=C/C1=CC(OC)=C(O)C=C1)[C@@H]1O[C@@]12CO
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   n.a.
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000476] Cinnamic acids and derivatives
        • [CHEMONTID:0001391] Hydroxycinnamic acids and derivatives
          • [CHEMONTID:0000059] Coumaric acids and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO9835 Catalpa ovata Species Bignoniaceae Eukaryota stem bark Medicinal Plant Garden, College of Pharmacy, Ewha Womans University 2013-DEC PMID[28787158]
NPO9835 Catalpa ovata Species Bignoniaceae Eukaryota n.a. n.a. n.a. PMID[9599262]
NPO9835 Catalpa ovata Species Bignoniaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO9835 Catalpa ovata Species Bignoniaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO9835 Catalpa ovata Species Bignoniaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO9835 Catalpa ovata Species Bignoniaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC478248 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9664 High Similarity NPC89693
0.9664 High Similarity NPC478241
0.9664 High Similarity NPC229548
0.953 High Similarity NPC478249
0.953 High Similarity NPC269914
0.9463 High Similarity NPC147224
0.9416 High Similarity NPC478265
0.9329 High Similarity NPC308178
0.9262 High Similarity NPC18789
0.9195 High Similarity NPC474234
0.9103 High Similarity NPC179914
0.9097 High Similarity NPC478266
0.906 High Similarity NPC478240
0.9 High Similarity NPC301910
0.9 High Similarity NPC130730
0.8993 High Similarity NPC302286
0.8993 High Similarity NPC116104
0.8993 High Similarity NPC88754
0.8993 High Similarity NPC237872
0.8993 High Similarity NPC263397
0.8944 High Similarity NPC208818
0.894 High Similarity NPC37838
0.8874 High Similarity NPC252292
0.8874 High Similarity NPC100998
0.8874 High Similarity NPC34587
0.8874 High Similarity NPC34927
0.8874 High Similarity NPC476382
0.8859 High Similarity NPC46644
0.8839 High Similarity NPC478268
0.8831 High Similarity NPC470934
0.8831 High Similarity NPC188393
0.8827 High Similarity NPC286809
0.8812 High Similarity NPC206815
0.8812 High Similarity NPC476011
0.8808 High Similarity NPC110063
0.8808 High Similarity NPC251062
0.8808 High Similarity NPC184464
0.88 High Similarity NPC140502
0.879 High Similarity NPC475484
0.8784 High Similarity NPC304152
0.8773 High Similarity NPC21956
0.8758 High Similarity NPC232992
0.8725 High Similarity NPC226005
0.8725 High Similarity NPC49597
0.8718 High Similarity NPC203664
0.8716 High Similarity NPC157554
0.8688 High Similarity NPC138993
0.8688 High Similarity NPC474936
0.8667 High Similarity NPC202700
0.8645 High Similarity NPC478242
0.8645 High Similarity NPC259347
0.8645 High Similarity NPC476386
0.8645 High Similarity NPC476398
0.8645 High Similarity NPC94871
0.8645 High Similarity NPC470933
0.8645 High Similarity NPC471062
0.8645 High Similarity NPC473427
0.8645 High Similarity NPC306890
0.8627 High Similarity NPC216819
0.8627 High Similarity NPC262182
0.8627 High Similarity NPC83743
0.8627 High Similarity NPC287615
0.8618 High Similarity NPC478239
0.8618 High Similarity NPC186296
0.8616 High Similarity NPC11411
0.8609 High Similarity NPC7518
0.8609 High Similarity NPC154262
0.8609 High Similarity NPC159387
0.8609 High Similarity NPC137501
0.8609 High Similarity NPC472711
0.86 High Similarity NPC100389
0.859 High Similarity NPC257970
0.859 High Similarity NPC470927
0.8581 High Similarity NPC35731
0.8571 High Similarity NPC476865
0.8562 High Similarity NPC470235
0.8562 High Similarity NPC129417
0.8562 High Similarity NPC283995
0.8562 High Similarity NPC297342
0.8562 High Similarity NPC84181
0.8553 High Similarity NPC157816
0.8544 High Similarity NPC229354
0.8537 High Similarity NPC475621
0.8537 High Similarity NPC282551
0.8535 High Similarity NPC475379
0.8528 High Similarity NPC109990
0.8526 High Similarity NPC106138
0.8509 High Similarity NPC478269
0.8509 High Similarity NPC469384
0.8506 High Similarity NPC476864
0.8506 High Similarity NPC476866
0.8506 High Similarity NPC476868
0.8506 High Similarity NPC476869
0.85 High Similarity NPC228357
0.8497 Intermediate Similarity NPC278961
0.8497 Intermediate Similarity NPC113680
0.8497 Intermediate Similarity NPC470950
0.8497 Intermediate Similarity NPC46092
0.8497 Intermediate Similarity NPC185307
0.8497 Intermediate Similarity NPC477898
0.8491 Intermediate Similarity NPC478232
0.8487 Intermediate Similarity NPC186406
0.8487 Intermediate Similarity NPC134405
0.8487 Intermediate Similarity NPC476385
0.8477 Intermediate Similarity NPC321638
0.8477 Intermediate Similarity NPC197316
0.8477 Intermediate Similarity NPC472350
0.8477 Intermediate Similarity NPC321184
0.8477 Intermediate Similarity NPC171134
0.8477 Intermediate Similarity NPC81515
0.8477 Intermediate Similarity NPC476383
0.8477 Intermediate Similarity NPC328273
0.8477 Intermediate Similarity NPC89105
0.8477 Intermediate Similarity NPC64141
0.8477 Intermediate Similarity NPC68092
0.8471 Intermediate Similarity NPC117346
0.8471 Intermediate Similarity NPC240592
0.8467 Intermediate Similarity NPC177035
0.8467 Intermediate Similarity NPC199459
0.8467 Intermediate Similarity NPC37468
0.8467 Intermediate Similarity NPC52277
0.8467 Intermediate Similarity NPC186418
0.8466 Intermediate Similarity NPC145847
0.8462 Intermediate Similarity NPC300262
0.8462 Intermediate Similarity NPC192763
0.8462 Intermediate Similarity NPC3460
0.8462 Intermediate Similarity NPC261122
0.8462 Intermediate Similarity NPC210611
0.8462 Intermediate Similarity NPC28651
0.8462 Intermediate Similarity NPC215095
0.8462 Intermediate Similarity NPC201148
0.8462 Intermediate Similarity NPC80732
0.8462 Intermediate Similarity NPC199311
0.8456 Intermediate Similarity NPC470881
0.8452 Intermediate Similarity NPC199928
0.8452 Intermediate Similarity NPC112861
0.8447 Intermediate Similarity NPC286919
0.8447 Intermediate Similarity NPC475663
0.8446 Intermediate Similarity NPC473285
0.8442 Intermediate Similarity NPC296954
0.8442 Intermediate Similarity NPC300894
0.8442 Intermediate Similarity NPC141455
0.8442 Intermediate Similarity NPC196063
0.8442 Intermediate Similarity NPC232228
0.8442 Intermediate Similarity NPC476867
0.8438 Intermediate Similarity NPC38699
0.8431 Intermediate Similarity NPC476356
0.8431 Intermediate Similarity NPC67467
0.8431 Intermediate Similarity NPC222433
0.8431 Intermediate Similarity NPC265648
0.8428 Intermediate Similarity NPC299706
0.8428 Intermediate Similarity NPC115466
0.8428 Intermediate Similarity NPC61604
0.8428 Intermediate Similarity NPC245615
0.8411 Intermediate Similarity NPC78363
0.8411 Intermediate Similarity NPC260425
0.8411 Intermediate Similarity NPC476376
0.8408 Intermediate Similarity NPC283839
0.8408 Intermediate Similarity NPC96599
0.8408 Intermediate Similarity NPC90896
0.8405 Intermediate Similarity NPC149873
0.8405 Intermediate Similarity NPC478267
0.8405 Intermediate Similarity NPC7191
0.8389 Intermediate Similarity NPC254398
0.8389 Intermediate Similarity NPC6836
0.8387 Intermediate Similarity NPC279298
0.8387 Intermediate Similarity NPC18979
0.8387 Intermediate Similarity NPC22150
0.8387 Intermediate Similarity NPC38041
0.8385 Intermediate Similarity NPC475378
0.8385 Intermediate Similarity NPC163635
0.8378 Intermediate Similarity NPC65942
0.8378 Intermediate Similarity NPC248307
0.8377 Intermediate Similarity NPC105005
0.8366 Intermediate Similarity NPC476377
0.8366 Intermediate Similarity NPC47471
0.8365 Intermediate Similarity NPC194705
0.8355 Intermediate Similarity NPC205195
0.8354 Intermediate Similarity NPC69367
0.8354 Intermediate Similarity NPC475224
0.8344 Intermediate Similarity NPC471988
0.8333 Intermediate Similarity NPC287597
0.8333 Intermediate Similarity NPC470685
0.8333 Intermediate Similarity NPC229505
0.8333 Intermediate Similarity NPC34293
0.8333 Intermediate Similarity NPC886
0.8333 Intermediate Similarity NPC471883
0.8333 Intermediate Similarity NPC226759
0.8333 Intermediate Similarity NPC135127
0.8323 Intermediate Similarity NPC296659
0.8323 Intermediate Similarity NPC118385
0.8323 Intermediate Similarity NPC187774
0.8323 Intermediate Similarity NPC202391
0.8323 Intermediate Similarity NPC473046
0.8323 Intermediate Similarity NPC472713
0.8323 Intermediate Similarity NPC292443
0.8323 Intermediate Similarity NPC472712
0.8322 Intermediate Similarity NPC252833
0.8322 Intermediate Similarity NPC473924
0.8313 Intermediate Similarity NPC469699

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC478248 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8841 High Similarity NPD7685 Pre-registration
0.8477 Intermediate Similarity NPD7266 Discontinued
0.8063 Intermediate Similarity NPD1653 Approved
0.7836 Intermediate Similarity NPD7228 Approved
0.7784 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7633 Intermediate Similarity NPD6234 Discontinued
0.7545 Intermediate Similarity NPD37 Approved
0.7544 Intermediate Similarity NPD7199 Phase 2
0.7543 Intermediate Similarity NPD7074 Phase 3
0.7532 Intermediate Similarity NPD3027 Phase 3
0.7516 Intermediate Similarity NPD6653 Approved
0.7515 Intermediate Similarity NPD4967 Phase 2
0.7515 Intermediate Similarity NPD4966 Approved
0.7515 Intermediate Similarity NPD4965 Approved
0.75 Intermediate Similarity NPD3620 Phase 2
0.75 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7486 Intermediate Similarity NPD7054 Approved
0.7485 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7453 Intermediate Similarity NPD6674 Discontinued
0.7443 Intermediate Similarity NPD7472 Approved
0.7442 Intermediate Similarity NPD8127 Discontinued
0.7438 Intermediate Similarity NPD5762 Approved
0.7438 Intermediate Similarity NPD5763 Approved
0.7429 Intermediate Similarity NPD3818 Discontinued
0.736 Intermediate Similarity NPD7240 Approved
0.7356 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7351 Intermediate Similarity NPD3705 Approved
0.7321 Intermediate Similarity NPD7028 Phase 2
0.7278 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD1613 Approved
0.7263 Intermediate Similarity NPD7251 Discontinued
0.7256 Intermediate Similarity NPD6190 Approved
0.7222 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD7808 Phase 3
0.7209 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7207 Intermediate Similarity NPD6797 Phase 2
0.7193 Intermediate Similarity NPD8455 Phase 2
0.7179 Intermediate Similarity NPD2861 Phase 2
0.717 Intermediate Similarity NPD4140 Approved
0.7152 Intermediate Similarity NPD1357 Approved
0.7143 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7125 Intermediate Similarity NPD5735 Approved
0.7124 Intermediate Similarity NPD1091 Approved
0.7088 Intermediate Similarity NPD8312 Approved
0.7088 Intermediate Similarity NPD8313 Approved
0.7083 Intermediate Similarity NPD7314 Clinical (unspecified phase)
0.7072 Intermediate Similarity NPD6559 Discontinued
0.7069 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7053 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7051 Intermediate Similarity NPD3094 Phase 2
0.7037 Intermediate Similarity NPD7097 Phase 1
0.7035 Intermediate Similarity NPD1934 Approved
0.7025 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7022 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7022 Intermediate Similarity NPD6166 Phase 2
0.7022 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7012 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7012 Intermediate Similarity NPD6005 Phase 3
0.7012 Intermediate Similarity NPD6004 Phase 3
0.7012 Intermediate Similarity NPD6002 Phase 3
0.7012 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.6995 Remote Similarity NPD7680 Approved
0.6989 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6988 Remote Similarity NPD4628 Phase 3
0.6988 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6988 Remote Similarity NPD4110 Phase 3
0.6962 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6959 Remote Similarity NPD228 Approved
0.6957 Remote Similarity NPD4060 Phase 1
0.6943 Remote Similarity NPD6362 Approved
0.6923 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6915 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6914 Remote Similarity NPD6355 Discontinued
0.6914 Remote Similarity NPD5124 Phase 1
0.6914 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6906 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6906 Remote Similarity NPD5844 Phase 1
0.6905 Remote Similarity NPD5058 Phase 3
0.6897 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6897 Remote Similarity NPD1465 Phase 2
0.6886 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6886 Remote Similarity NPD8166 Discontinued
0.6882 Remote Similarity NPD6273 Approved
0.6875 Remote Similarity NPD7095 Approved
0.6867 Remote Similarity NPD5283 Phase 1
0.6865 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6855 Remote Similarity NPD5736 Approved
0.6845 Remote Similarity NPD6843 Phase 3
0.6845 Remote Similarity NPD6841 Approved
0.6845 Remote Similarity NPD6842 Approved
0.6826 Remote Similarity NPD1652 Phase 2
0.681 Remote Similarity NPD230 Phase 1
0.6807 Remote Similarity NPD1375 Discontinued
0.68 Remote Similarity NPD2978 Approved
0.68 Remote Similarity NPD2977 Approved
0.6796 Remote Similarity NPD7473 Discontinued
0.6795 Remote Similarity NPD3092 Approved
0.6792 Remote Similarity NPD5647 Approved
0.678 Remote Similarity NPD7075 Discontinued
0.6776 Remote Similarity NPD7157 Approved
0.6768 Remote Similarity NPD6353 Approved
0.6761 Remote Similarity NPD3817 Phase 2
0.6758 Remote Similarity NPD3751 Discontinued
0.6757 Remote Similarity NPD7549 Discontinued
0.6733 Remote Similarity NPD7930 Approved
0.6728 Remote Similarity NPD6410 Clinical (unspecified phase)
0.6725 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6724 Remote Similarity NPD4380 Phase 2
0.6723 Remote Similarity NPD3882 Suspended
0.6722 Remote Similarity NPD6232 Discontinued
0.6709 Remote Similarity NPD5327 Phase 3
0.6708 Remote Similarity NPD4908 Phase 1
0.6707 Remote Similarity NPD3657 Discovery
0.6705 Remote Similarity NPD3686 Approved
0.6705 Remote Similarity NPD2801 Approved
0.6705 Remote Similarity NPD3687 Approved
0.6704 Remote Similarity NPD5494 Approved
0.6689 Remote Similarity NPD7843 Approved
0.6689 Remote Similarity NPD1358 Approved
0.6688 Remote Similarity NPD5536 Phase 2
0.6687 Remote Similarity NPD6663 Approved
0.6687 Remote Similarity NPD4624 Approved
0.6687 Remote Similarity NPD7033 Discontinued
0.6685 Remote Similarity NPD7975 Clinical (unspecified phase)
0.6667 Remote Similarity NPD2424 Discontinued
0.6667 Remote Similarity NPD4626 Approved
0.6667 Remote Similarity NPD7799 Discontinued
0.6667 Remote Similarity NPD7999 Approved
0.6667 Remote Similarity NPD7458 Discontinued
0.6649 Remote Similarity NPD7296 Approved
0.6646 Remote Similarity NPD9494 Approved
0.663 Remote Similarity NPD3787 Discontinued
0.6627 Remote Similarity NPD5698 Clinical (unspecified phase)
0.6627 Remote Similarity NPD4978 Clinical (unspecified phase)
0.6626 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6624 Remote Similarity NPD3496 Discontinued
0.6622 Remote Similarity NPD3134 Approved
0.661 Remote Similarity NPD5563 Clinical (unspecified phase)
0.661 Remote Similarity NPD7096 Clinical (unspecified phase)
0.661 Remote Similarity NPD7819 Suspended
0.6606 Remote Similarity NPD4340 Discontinued
0.6604 Remote Similarity NPD4749 Approved
0.6603 Remote Similarity NPD5691 Approved
0.66 Remote Similarity NPD3021 Approved
0.66 Remote Similarity NPD3022 Approved
0.6588 Remote Similarity NPD7982 Clinical (unspecified phase)
0.6587 Remote Similarity NPD4108 Discontinued
0.6585 Remote Similarity NPD6233 Phase 2
0.6584 Remote Similarity NPD6007 Clinical (unspecified phase)
0.6582 Remote Similarity NPD1610 Phase 2
0.6582 Remote Similarity NPD422 Phase 1
0.6573 Remote Similarity NPD5353 Approved
0.6566 Remote Similarity NPD7435 Discontinued
0.6566 Remote Similarity NPD7497 Discontinued
0.6562 Remote Similarity NPD8651 Approved
0.6561 Remote Similarity NPD5125 Phase 3
0.6561 Remote Similarity NPD5126 Approved
0.6558 Remote Similarity NPD6671 Approved
0.6554 Remote Similarity NPD7945 Clinical (unspecified phase)
0.6548 Remote Similarity NPD2935 Discontinued
0.6545 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6543 Remote Similarity NPD7312 Approved
0.6543 Remote Similarity NPD7310 Approved
0.6543 Remote Similarity NPD7311 Approved
0.6543 Remote Similarity NPD7313 Approved
0.6538 Remote Similarity NPD3091 Approved
0.6533 Remote Similarity NPD2684 Approved
0.6529 Remote Similarity NPD4237 Approved
0.6529 Remote Similarity NPD4236 Phase 3
0.6527 Remote Similarity NPD4537 Clinical (unspecified phase)
0.6527 Remote Similarity NPD4536 Approved
0.6527 Remote Similarity NPD4538 Approved
0.6526 Remote Similarity NPD8434 Phase 2
0.6524 Remote Similarity NPD3764 Approved
0.6524 Remote Similarity NPD6798 Discontinued
0.6517 Remote Similarity NPD5761 Phase 2
0.6517 Remote Similarity NPD5760 Phase 2
0.6514 Remote Similarity NPD4210 Discontinued
0.6509 Remote Similarity NPD2029 Clinical (unspecified phase)
0.6508 Remote Similarity NPD7309 Approved
0.6506 Remote Similarity NPD1933 Approved
0.6506 Remote Similarity NPD447 Suspended
0.65 Remote Similarity NPD2982 Phase 2
0.65 Remote Similarity NPD2983 Phase 2
0.6497 Remote Similarity NPD6386 Approved
0.6497 Remote Similarity NPD6385 Approved
0.6491 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6491 Remote Similarity NPD6331 Phase 2
0.6488 Remote Similarity NPD5960 Phase 3
0.6488 Remote Similarity NPD5588 Approved
0.6485 Remote Similarity NPD8151 Discontinued
0.648 Remote Similarity NPD5402 Approved
0.6474 Remote Similarity NPD4357 Discontinued
0.6474 Remote Similarity NPD1511 Approved
0.6471 Remote Similarity NPD970 Clinical (unspecified phase)
0.6467 Remote Similarity NPD2492 Phase 1
0.6467 Remote Similarity NPD2898 Approved
0.6461 Remote Similarity NPD6801 Discontinued
0.645 Remote Similarity NPD2161 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data